Clinicians rightly celebrate when treatment ends. Yet many patients leave our clinics still carrying the invisible weight of illness—anxiety, low mood, pain, and a fragile sense of self. The evidence says this is not rare, and it is not trivial. A 2025 umbrella review of cancer survivorship found pooled prevalence rates of 33% for depression and 31% for anxiety, with higher figures during periods of wider societal stress. These symptoms shape adherence, function, and quality of life, long after
Read More
Cancer Detection
MedStar Health Pilots On-Demand Cancer Care with Reimagine Care
What You Should Know:
- Reimagine Care, the nation’s leading provider of on-demand cancer care, today announced a pilot collaboration with MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region.
- MedStar Health will integrate Reimagine Care’s innovative on-demand oncology care platform into its cancer care delivery model, offering patients a seamless extension from their in-clinic care plan into the home.
Extending High-Quality Cancer Care
Read More
AI Accelerates Cancer Research: ACS Partners with Layer Health for LLM Data Extraction
What You Should Know:
- The American Cancer Society (ACS) and Layer Health, an innovator in AI-driven healthcare technology, have announced a multi-year collaboration aimed at accelerating cancer research. This partnership will leverage large language models (LLMs) to streamline the extraction of vital clinical data from patient medical records.
- This collaboration builds upon a successful pilot program that focused on breast cancer patients. The pilot demonstrated the platform's
Read More
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection
What You Should Know:
- iCAD, Inc., a global leader in AI-powered cancer detection solutions, and RamSoft®, a provider of cloud-based radiology solutions announced a strategic partnership to integrate iCAD's ProFound AI® Breast Health Suite into RamSoft's PowerServer platform.
- The collaboration will bring advanced AI capabilities to imaging centers and healthcare providers across the US and Canada, enhancing breast cancer detection and improving patient care.
Addressing
Read More
Paige Expands PanCancer Detect to Identify Cancer in Over 40 Tissue Types
What You Should Know:
- Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
- Originally launched in 2024 with the ability to identify cancer in 17 tissue types, PanCancer Detect now supports over 40 tissue and organ types, thanks to advancements in Paige's AI foundation models.
AI-Powered Pathology Solution Enhances Diagnostic Accuracy and Efficiency
This
Read More
Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities
What You Should Know:
- Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
- The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients.
AI-Powered Lung Nodule Analysis
Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More
C the Signs Raises $8M to Expand AI-Powered Cancer Detection to the U.S.
What You Should Know:
- C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
- The investment will fuel the company's expansion from the United Kingdom, where it has already achieved significant success in early cancer detection, to the United States.
Cancer Screening and Improve Patient Outcomes
C the Signs addresses a critical gap in cancer care by identifying patients at risk of cancer at
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
AI Against Cancer: Capabilities and Limitations for Early Detection and Treatment Planning
The American Cancer Society predicted 2 million new cancer cases in the US alone in 2024, which amounts to roughly 5,480 diagnoses every day. What makes matters worse is that the pandemic delayed care for more than 75% of cancer patients. Unsurprisingly, healthcare providers are turning to new technologies like AI in search of solutions. To gauge the magnitude of this trend, consider this: as of August 7, 2024, 950 AI/ML-enabled medical devices have received clearance from the FDA, with 76% of
Read More
MedCognetics Unveils Embedded AI Cancer Detection System for Mammography Imaging
What You Should Know:
- MedCognetics, Inc., a company focusing on medical imaging AI, today announced the successful testing and implementation of the first embedded AI image processing and cancer detection system for mammography.
- The system utilizes the NVIDIA IGX OrinTM medical-grade edge AI platform alongside MedCognetics’ advanced AI-enabled software, CogNet AI-MT, which was developed in collaboration with clinical leaders worldwide. CogNet AI-MT has been trained on a diverse
Read More
